PubMed:30843003 / 223-410
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/30843003","sourcedb":"PubMed","sourceid":"30843003","source_url":"https://www.ncbi.nlm.nih.gov/pubmed/30843003","text":"s at present the most commonly used biomarker for PCa screening, as well as a reliable marker of disease recurrence after initial treatment. Bone metastases (BM) are present in advanced s","tracks":[]}